Status:
UNKNOWN
Study on Early Lyme Neuroborreliosis
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Nervous System Lyme Borreliosis
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.
Eligibility Criteria
Inclusion
- erythema migrans within 4 months before neurologic involvement and pleocytosis in patients \>15 years old
Exclusion
- pregnancy
- lactation
- history of adverse reaction to a beta-lactam antibiotic
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00910533
Start Date
January 1 2009
End Date
December 1 2020
Last Update
October 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Ljubljana, Department of Infectious Diseases
Ljubljana, Slovenia, 1525